Email Updates
Study
Multilevel factors associated with time to biopsy after abnormal screening mammography results by race and ethnicity.
July 6, 2022
Lawson MB, Bissell MCS, Miglioretti DL, et al. JAMA Oncol. 2022;8(8):1115-1126.
Delays in breast cancer diagnosis and treatment can threaten patient safety. This study analyzed data from a large US breast cancer screening consortium to evaluate differences in diagnostic follow-up among racial and ethnic groups. Findings indicate that Black women were most likely to experience diagnostic delays (between receipt of abnormal screening result to biopsy) after adjusting for individual-, neighborhood-, and health care-level factor, emphasizing the need to address the potential for systemic racism in healthcare.
